(Q40858866)

24 September 2017

1 reference

title

Treatment of seizures in patients with learning disabilities (English)

1 reference

24 September 2017

0 references

Hannah JA

1

1 reference

24 September 2017

Brodie MJ

series ordinal

2

1 reference

24 September 2017

publication date

1 April 1998

1 reference

Pharmacology & Therapeutics

24 September 2017

published in

1 reference

24 September 2017

volume

78

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

1-8

1 reference

Vigabatrin in adults with poorly-controlled epilepsy and learning disabilities

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Surgical treatment for epilepsy in cerebral tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Relationship between anticonvulsant drugs and learning disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Lamotrigine--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

1 reference

7 January 2021

Established antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

The diversity of epilepsy in adults with severe developmental disabilities: age at seizure onset and other prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Non-convulsive status epilepticus in the adult mentally retarded. Classification and role of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Neuroleptic and antiepileptic treatment in the mentally retarded

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Long-term prognosis in childhood epilepsy: survival and seizure prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Epilepsy--a time for change?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

An epilepsy needs document

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Clinical and therapeutic monitoring of epilepsy in a mental handicap unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Comprehensive management of epilepsy in persons with mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Psychopathology of People with Mental Handicap and Epilepsy I: Maladaptive Behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

New antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

1 reference

7 January 2021

Learning disability and epilepsy. 2, a review of available outcome measures and position statement on development priorities.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Influence of lamotrigine addition on computerized background EEG parameters in severe epileptogenic encephalopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Epilepsy in a population of mentally retarded children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Influence of epilepsy on mortality in mental retardation: an epidemiologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Epilepsy in children with mental retardation: a cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Community-based study of mortality in children with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Prevalence of epilepsy in Rochester, Minnesota: 1940-1980.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Neuroradiological findings in the northern epilepsy syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Northern Epilepsy Syndrome: Clinical Course and the Effect of Medication on Seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Some issues in the assessment of epilepsy occurring in the context of learning disability in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Congenital bilateral perisylvian syndrome: analysis of the first four reported Korean patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Neuroimaging in pediatric epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Congenital bilateral perisylvian syndrome: study of 31 patients. The CBPS Multicenter Collaborative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Infantile spasms: an early epileptic manifestation in some patients with the congenital bilateral perisylvian syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Assessing seizure activity in mentally disabled adults

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

New antiepileptic drugs--an explosion of activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

A prospective study on sudden unexpected death in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

1 reference

7 January 2021

Vigabatrin in epilepsy in mentally retarded patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Prevalence and associated features of epilepsy in adults with Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Aicardi syndrome: natural history and possible predictors of severity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Epilepsy and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Epilepsy or stereotypy? Diagnostic issues in learning disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

A decade of modern epilepsy therapy in institutionalized mentally retarded patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

The new generation of antiepileptic drugs: advantages and disadvantages

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Epilepsy and associated effects on adaptive behaviour in adults with Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Seizure Disorders in Down Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy. Clinical, EEG and neuroimaging features in 100 adult patie

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Rational polypharmacy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Hypomania induced by gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Early clinical and EEG features of infantile spasms in Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Therapeutic intervention in mentally retarded adult epileptics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

The prevalence and costs of psychiatric disorders and learning disabilities.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Some issues in non-convulsive status epilepticus in children and adolescents with learning difficulties

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Characteristics of seizures in a population-based series of mentally retarded children with active epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Infantile spasms in children with Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Outcome of Sturge-Weber syndrome in 52 adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Seizure occurrence during long-term monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Magnetic resonance imaging in relation to EEG epileptic foci in tuberous sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

The use of high-dose antipsychotic medication

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

The impact of chronic epilepsy on the family

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Lamotrigine in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

On the incidence of fits and mental retardation in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Gabapentin toxicity in children manifesting as behavioral changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Gamma-vinyl GABA (vigabatrin) in epilepsy: clinical, neurochemical, and neurophysiologic monitoring in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Long-term efficacy and cognitive effects of vigabatrin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2897%2900153-8

7 January 2021

10.1016/S0163-7258(97)00153-8

Identifiers

DOI

1 reference

24 September 2017

1 reference